Squarepoint
VCYT icon

Squarepoint’s Veracyte VCYT Stock Holding History

Squarepoint’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-28,800
Closed -$1.14M – 5466
2024
Q4 		$1.14M Buy
+28,800
New +$1.09M ﹤0.01% 2941

Other funds holding VCYT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Squarepoint's VCYT Position: Q1 2026 in Review

Squarepoint opened a new position in Veracyte (VCYT) in Q1 2026: 64,154 shares worth $2.07M. The stake represents ﹤0.01% of the portfolio and ranks #2154 among its holdings. This is a return to the name: Squarepoint previously reported a position in VCYT as recently as Q3 2025.

Squarepoint first reported a position in VCYT in Q1 2017 and has held it in 29 quarters since. The position peaked at $24.3M in Q2 2025. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.

  • Squarepoint held 64,154 shares of Veracyte worth $2.07M as of Q1 2026.
  • Veracyte was a new Squarepoint position in Q1 2026.
  • Veracyte made up ﹤0.01% of Squarepoint's portfolio in Q1 2026, its #2154 holding.
  • Squarepoint first reported a position in Veracyte in Q1 2017 and has held it in 29 quarters since.
  • Squarepoint's Veracyte position peaked at $24.3M in Q2 2025.
  • 334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.